gut.bmjLíon na míonna: 2
Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial
The primary objective of the study was to demonstrate the superiority of pH-modified release oral budesonide (Budenofalk 3 mg capsules, Dr Falk Pharma GmbH, Freiburg, Germany) compared with placebo ...
gut.bmjLíon na míonna: 2
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
or Entocort EC 9 mg (budesonide controlled ileal-release capsules; reference arm) or placebo once daily for 8 weeks. The primary endpoint was combined clinical and endoscopic remission, defined as UC ...
NatureLíon na míonna: 5
Remission of lymphocytic colitis with budesonide
Data from a new randomized, placebo-controlled trial have demonstrated the efficacy of budesonide in inducing remission of this disease; this study is an important contribution to this field.
BMJ1y
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis
Methods: A double blind, randomised, controlled trial over 12 weeks in 143 patients with active rheumatoid arthritis, comparing budesonide 3 mg daily, budesonide 9 mg daily, prednisolone 7.5 mg daily, ...
Wellcome Collection4y
Drug Packaging ephemera. Box 1.
and Double Amplex (fresh breath capsules: Ashe Laboratories), Turbohaler budesonide / formoterol (AstraZeneca, 2011, 2012), Canesten cream (Bayer, 2009), Canesten Cream (fungal infections, nappy rash) ...